Treatment of gastroparesis

Current Treatment Options in Gastroenterology

Volumn 7, Issue 2, 2004, Pages 139-147

  Buckles, Daniel C ^a   McCallum, Richard W ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTIEMETIC AGENT; BOTULINUM TOXIN A; CISAPRIDE; DOLASETRON MESILATE; DOMPERIDONE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DRONABINOL; ERYTHROMYCIN; GRANISETRON; HORMONE RECEPTOR; MACROLIDE; METOCLOPRAMIDE; METRONIDAZOLE; MITEMCINAL; MOSAPRIDE CITRATE; MOTILIN; NORTRIPTYLINE; OCTREOTIDE; ONDANSETRON; PROCHLORPERAZINE; PROKINETIC AGENT; PROMETHAZINE; SCOPOLAMINE; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 AGONIST; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTICHOLINERGIC EFFECT; ANTIEMETIC ACTIVITY; BREAST DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC DISEASE; CLINICAL TRIAL; CONFUSION; DIARRHEA; DISABILITY; DRUG COST; DRUG EFFICACY; DRUG PENETRATION; DRUG TOLERABILITY; ELECTROSTIMULATION; EUPHORIA; EXTRAPYRAMIDAL SYMPTOM; GYNECOMASTIA; HUMAN; NAUSEA AND VOMITING; NUTRITIONAL STATUS; QUALITY OF LIFE; REVIEW; SEDATION; SOMNOLENCE; STOMACH MOTILITY; STOMACH PARESIS; SYMPTOMATOLOGY; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 3142773367     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-004-0035-z     Document Type: Review

References (30)

1. Hornbuckle K, Barnett JL: The diagnosis and work up of the patient with gastroparesis. J Clin Gastroenterol 2000, 30:117-124.
2. Kendall BJ, McCallum RW: Gastroparesis and the current use of prokinetic drugs. Gastroenterologist 1993, 1:107-114.
3. Hinder RA, Kelly KA: Human gastric pacesetter potential: site of origin, spread, and response to gastric transection and proximal gastric agronomy. Am J Surg 1978, 133:29-33.
4. Tonzi MK, Fain JA: Understanding diabetic gastroparesis. A case study. Gastroenterol Nurs 2002, 25:154-160.
5. Soykan I, Sivri B, Sarosiek I, et al.: Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 1998, 43:2398-2404.
6. Walsh JW, Hasler WL, Nugent CE, et al.: Progesterone and estrogen are potential mediators of gastric slow wave dysrhythmias in nausea of pregnancy. Am J Physiol Gastrointest Liver Physiol 1996, 270:G506-G514.
7. Tougas G, Eaker EY, McCallum RW, et al.: Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000, 95:1456-1462.
8. Nilsson PH: Diabetic gastroparesis: a review. J Diabetes Comp 1996, 10:113-122.
9. Ricci DA, Saltzman MB, McCallum RW, et al.: Effect of metoclopramide in diabetic gastroparesis. J Clin Gastroenterol 1985, 7:25-32.
10. Albibi R, McCallum RW: Metoclopramide: pharmacology and clinical application. Ann Intern Med 1983, 98:86-95.
11. McCallum RW, Valenzuela G, Spyker D, et al.: Subcutaneous metoclopramide in the treatment of symptomatic gastro paresis: clinical efficacy and pharmacokinetics. J Pharmacol Exp Ther 1991, 258:136-142.
12. Dumitrascu DL, Weinbeck M: Domperidone versus metoclopramide in the treatment of diabetic gastroparesis. Am J Gastroenterol 2000, 95:316-317.
13. Soykan I, Sarosiek I, McCallum R: The effect of chronic oral domperidone therapy on the gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol 1997, 92:976-980.
14. Silvers D, Kipnes M, Broadstone V, et al.: Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. Clin Ther 1998, 20:438-453.
15. Richards RD, Davenport K, McCallum RW: The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 1993, 88:203-207.
16. Peeters TL: GM-611 (Chugai Pharmaceutical). Curr Opin Invest Drugs 2001, 2:555-557.
17. Camilleri M, Malagelada JR, Abell TR, et al.: Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology 1989, 96:704-712.
18. Endo J, Nomura M, Morishita S, et al.: Influence of mosapride citrate on gastric motility and autonomic nervous function: evaluation by spectral analyses of heart rate and blood pressure variabilities, and by electrogastrography. J Gastroenterol 2002, 37:888-895.
19. Prather CM, Camilleri M, Zinsmeister AR, et al.: Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterol 2000, 118:463-468.
20. Tougas G, Chen Y, Luo D, et al.: Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms [abstract]. Gastroenterology 2003, 124:A54.
21. Lane M, Vogel CL, Ferguson J, et al.: Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting. J Pain Symptom Manage 1991, 6:352-359.
22. Miller LS, Szych GA, Kantor SB, et al.: Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 2002, 97:1653-1660.
23. Lacy BE, Zayat EN, Crowell MD, et al.: Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol 2002, 97:1548-1552.
24. Ezzeddine D, Jit R, Katz N, et al.: Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc 2002, 55:920-923.
25. Forster J, Sarosiek I, Delcore R, et al.: Gastric pacing is a new surgical treatment for gastroparesis. Am J Surg 2001, 182:676-681.
26. Abell TF, McCallum RW, Hocking M, et al.: Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003, 125:421-428.
27. McElhinney C, Sarosiek I, Lin Z, et al.: Comparison of hospitalizations, medications, and quality of life in patients receiving gastric electrical stimulation therapy (GES) for severe gastroparesis. Gastroenterology 2001, 122:A676.
28. Akindipe OA, Faul JL, Vierra MA, et al.: The surgical management of severe gastroparesis in heart/lung transplant recipients. Chest. 2000, 117:907-910.
29. McCallum RW, Polepalle SC, Schirmer B: Completion gastrectomy for refractory gastroparesis following surgery for peptic ulcer disease. Long-term follow-up with subjective and objective parameters. Dig Dis Sci 1991, 36:1556-1561.
30. Watkins PJ, Buxton-Thomas MS, Howard ER: Long-term outcome after gastrectomy for intractable diabetic gastroparesis. Diabetes Med 2003, 20:58-63.